Coherus Oncology Inc.
ABOUT US
Coherus Oncology is focused on developing and commercializing a diversified portfolio of next-generation immuno-oncology therapies that potentially extend patient survival across tumor types.
333 Twin Dolphin Drive, Ste 600
Redwood City, CA 94065
(800) 794-5434
PRIMARY CONTACTS
Bill Asbury
Senior Director, National Accounts
(973) 970-4933
basbury@coherus.com
Shardae Young
Senior Medical Science Liaison
(708) 831-1750
syoung@coherus.com
PRODUCTS OR SERVICES
The approval of LOQTORZI® (toripalimab-tpzi) for nasopharyngeal carcinoma and the advancement of multiple clinical stage immuno-oncology candidates targeting the tumor microenvironment underscore our commitment to immuno-oncology as a means for providing better treatment outcomes for patients with life-altering illnesses.